Manufacturing Tanabe pens deal to sell plants to Towa in post-buyout pivot BioSpaceAfter being bought by Bain for $3.3 billion, Tanabe has reached a deal to sell its manufacturing unit and 17 products.Read full story pharminent July 8, 2026 (Last updated: July 9, 2026) BioSpace After being bought by Bain for $3.3 billion, Tanabe has reached a deal to sell its manufacturing unit and 17 products. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: AstraZeneca, GSK intensify China ties with Sino Biopharm dealsNext: Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens Partnership With GSK Related Stories Manufacturing FDA Warning Letter Hits Sanofi’s Genzyme Ireland Site pharminent July 8, 2026 Manufacturing FDA Selects Seven for PreCheck Pilot to Advance Drug Manufacturing pharminent July 1, 2026 Manufacturing SK pharmteco Launches SKyvec Viral Vector Platform for Gene Therapy pharminent June 24, 2026
